nimbolide has been researched along with Astrocytoma, Grade IV in 2 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 1 (50.00) | 24.3611 |
| 2020's | 1 (50.00) | 2.80 |
| Authors | Studies |
|---|---|
| Aggarwal, N; Bharti, AC; Chaudhary, A; Chhokar, A; Goswami, N; Janjua, D; Joshi, U; Senrung, A; Tripathi, T; Yadav, J | 1 |
| Anderson, J; Chhipa, RR; Clark, JP; Dasgupta, B; Gasilina, A; Ghosh, J; Ghosh, PK; Henry, H; Karkare, S; Kumar, A; Liu, X; Nassar, N; Pauletti, GM | 1 |
2 other study(ies) available for nimbolide and Astrocytoma, Grade IV
| Article | Year |
|---|---|
In vivo antiangiogenic effect of nimbolide, trans-chalcone and piperine for use against glioblastoma.
Topics: Angiogenesis Inhibitors; Cell Line, Tumor; Chalcones; Glioblastoma; Humans; Neovascularization, Pathologic; Vascular Endothelial Growth Factor A; Vascular Endothelial Growth Factor Receptor-2 | 2023 |
Direct inhibition of retinoblastoma phosphorylation by nimbolide causes cell-cycle arrest and suppresses glioblastoma growth.
Topics: Animals; Antineoplastic Agents, Phytogenic; Azadirachta; Brain Neoplasms; Cell Line, Tumor; Cyclin-Dependent Kinase 4; Cyclin-Dependent Kinase 6; ErbB Receptors; G1 Phase Cell Cycle Checkpoints; Glioblastoma; Humans; Limonins; Male; Mice; Mice, Nude; Phosphorylation; Plant Extracts; Plant Leaves; Protein Processing, Post-Translational; Retinoblastoma Protein; Tumor Burden; Xenograft Model Antitumor Assays | 2014 |